Stocks and Investing Stocks and Investing
Tue, February 2, 2021
[ 12:00 AM ] - WOPRAI
Josh Beck Maintained (BILL) at Buy with Increased Target to $150 on, Feb 2nd, 2021
[ 12:00 AM ] - WOPRAI
Josh Beck Maintained (BL) at Buy with Increased Target to $145 on, Feb 2nd, 2021
[ 12:00 AM ] - WOPRAI
Patrick Walravens Maintained (BL) at Buy with Increased Target to $163 on, Feb 2nd, 2021
Mon, February 1, 2021
[ 12:00 AM ] - WOPRAI
Adam Jonas Downgraded (SPCE) to Hold and Increased Target to $600 on, Feb 1st, 2021
[ 12:00 AM ] - WOPRAI
Todd Fowler Upgraded (SNDR) to Buy and Held Target at $25 on, Feb 1st, 2021
[ 12:00 AM ] - WOPRAI
Stephen Ju Maintained (SNAP) at Buy with Increased Target to $59 on, Feb 1st, 2021
[ 12:00 AM ] - WOPRAI
Ian Macpherson Maintained (BKR) at Buy with Increased Target to $30 on, Feb 1st, 2021
[ 12:00 AM ] - WOPRAI
Hamir Patel Initiated (BLDP) at Hold and Held Target at $38 on, Feb 1st, 2021
[ 12:00 AM ] - WOPRAI
Courtney Yakavonis Maintained (CAT) at Sell with Increased Target to $158 on, Feb 1st, 2021
[ 12:00 AM ] - WOPRAI
Nicole Deblase Maintained (CAT) at Strong Buy with Increased Target to $233 on, Feb 1st, 2021
[ 12:00 AM ] - WOPRAI
Jamie Cook Maintained (CAT) at Buy with Increased Target to $235 on, Feb 1st, 2021
[ 12:00 AM ] - WOPRAI
Joel Tiss Maintained (CAT) at Hold with Increased Target to $190 on, Feb 1st, 2021
[ 12:00 AM ] - WOPRAI
Alexander Potter Maintained (TSLA) at Buy with Increased Target to $400 on, Feb 1st, 2021
[ 12:00 AM ] - WOPRAI
William Katz Maintained (TROW) at Hold with Decreased Target to $153 on, Feb 1st, 2021
[ 12:00 AM ] - WOPRAI
PJ Juvekar Maintained (CE) at Strong Buy with Decreased Target to $144 on, Feb 1st, 2021
[ 12:00 AM ] - WOPRAI
Benjamin Chaiken Maintained (VAC) at Buy with Increased Target to $199 on, Feb 1st, 2021
[ 12:00 AM ] - WOPRAI
William Wallace Maintained (UVSP) at Buy with Increased Target to $27 on, Feb 1st, 2021
[ 12:00 AM ] - WOPRAI
Andrew Fein Upgraded (UTHR) to Strong Buy and Increased Target to $195 on, Feb 1st, 2021
[ 12:00 AM ] - WOPRAI
John Eade Maintained (URI) at Strong Buy with Increased Target to $280 on, Feb 1st, 2021
[ 12:00 AM ] - WOPRAI
David Feaster Maintained (ABCB) at Strong Buy with Increased Target to $46 on, Feb 1st, 2021
[ 12:00 AM ] - WOPRAI
Betsy Graseck Maintained (SYF) at Buy with Increased Target to $53 on, Feb 1st, 2021
[ 12:00 AM ] - WOPRAI
Meng Jiao Maintained (SYF) at Strong Buy with Increased Target to $54 on, Feb 1st, 2021
[ 12:00 AM ] - WOPRAI
Markus Mittermaier Maintained (SWK) at Strong Buy with Increased Target to $241 on, Feb 1st, 2021
[ 12:00 AM ] - WOPRAI
Jason Helfstein Maintained (BIDU) at Buy with Increased Target to $305 on, Feb 1st, 2021
[ 12:00 AM ] - WOPRAI
Shawn Collins Maintained (BC) at Hold with Increased Target to $94 on, Feb 1st, 2021
[ 12:00 AM ] - WOPRAI
Gerrick Johnson Maintained (BC) at Hold with Increased Target to $95 on, Feb 1st, 2021
[ 12:00 AM ] - WOPRAI
Michael Lasser Downgraded (WSM) to Strong Sell and Held Target at $55 on, Feb 1st, 2021
[ 12:00 AM ] - WOPRAI
Nick Setyan Maintained (WING) at Buy with Increased Target to $175 on, Feb 1st, 2021
[ 12:00 AM ] - WOPRAI
Daniel Mckenzie Downgraded (AAL) to Hold on, Feb 1st, 2021
[ 12:00 AM ] - WOPRAI
Colin Bristow Initiated (BTAI) at Strong Buy and Held Target at $99 on, Feb 1st, 2021

Colin Bristow Initiated (BTAI) at Strong Buy and Held Target at $99 on, Feb 1st, 2021


Published on 2024-10-27 15:27:13 - WOPRAI, Colin Bristow
  Print publication without navigation


Colin Bristow of UBS, Initiated "BioXcel Therapeutics, Inc." (BTAI) at Strong Buy and Held Target at $99 on, Feb 1st, 2021.

Colin has made no other calls on BTAI in the last 4 months.



There is 1 other peer that has a rating on BTAI. Out of the 1 peers that are also analyzing BTAI, 0 agree with Colin's Rating of Hold.



This is the rating of the analyst that currently disagrees with Colin

  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $185 on, Wednesday, January 6th, 2021
Contributing Sources